Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Has Average Target Price of $26.67
Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twelve research firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, eight have assigned a buy recommendation and […]
20 Oct 11:15 · The Markets Daily